Ost-müük Myriad Genetics - MYGN CFD
Lisa lemmikuks- Kokkuvõte
- Ajaloolised andmed
- Sündmused
- Tuluaruanne
- Bilanss
- Rahavood
- Omand
Hinnavahe | - | ||||||||
Pika positsiooni ööpäeva tasu
Long position overnight fee
Mine platvormile | -0.025457% | ||||||||
Lühikese positsiooni ööpäeva tasu
Short position overnight fee
Mine platvormile | 0.003235% | ||||||||
Ööpäeva tasu aeg | 21:00 (UTC) | ||||||||
Min kauplemise kogus | 1 | ||||||||
Valuuta | USD | ||||||||
Tagatis | 20% | ||||||||
Aktsiabörs | United States of America | ||||||||
Kauplemise vahendustasu | 0% |
*Information provided by Capital.com
Myriad Genetics Inc ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Eelmine sulgemine* | N/A |
Avatud* | N/A |
Aastane muutus* | N/A |
Päeva ulatus* | N/A |
52 nädala ulatus | 13.92-28.18 |
Keskmine maht (10 päeva) | 657.17K |
Keskmine maht (3 kuud) | 12.42M |
Turukapitalisatsioon | 1.83B |
P/E suhtarv | -100.00K |
Ringluses olevad aktsiad | 81.56M |
Tulu | 694.70M |
EPS | -1.80 |
Dividendid (% kasumist) | N/A |
Beeta | 1.82 |
Järgmine tuluaruande kuupäev | Aug 2, 2023 |
Kõigi andmete allikas on Refinitiv, välja arvatud tärniga märgitud, kus *-ga andmed on esitanud Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Sulgemishind | Change (%) | Avamishind | High | Low |
---|
Myriad Genetics Events
Kellaaeg (UTC) (UTC) | Riik | Sündmus |
---|---|---|
Wednesday, August 2, 2023 | ||
Kellaaeg (UTC) (UTC) 12:30 | Riik US
| Sündmus Q2 2023 Myriad Genetics Inc Earnings Release Q2 2023 Myriad Genetics Inc Earnings ReleaseForecast -Previous - |
Monday, October 30, 2023 | ||
Kellaaeg (UTC) (UTC) 12:30 | Riik US
| Sündmus Q3 2023 Myriad Genetics Inc Earnings Release Q3 2023 Myriad Genetics Inc Earnings ReleaseForecast -Previous - |
- Aastas
- Kvartalis
2022 | 2021 | 2020 | 2020 | 2019 | |
---|---|---|---|---|---|
Kogutulu | 678.4 | 690.6 | 299.8 | 638.6 | 851.1 |
Tulu | 678.4 | 690.6 | 299.8 | 638.6 | 851.1 |
Kulud, Kokku | 202 | 197.6 | 91.4 | 186.1 | 201 |
Brutokasum | 476.4 | 493 | 208.4 | 452.5 | 650.1 |
Kogu tegevuskulu | 819 | 740.6 | 387.6 | 869.3 | 843.5 |
Müük/Üldine/admin kulud, kokku | 514.7 | 537.8 | 256.9 | 510.1 | 548.7 |
Uuringud ja arendus | 85.4 | 81.9 | 35.8 | 77.2 | 68.6 |
Other Operating Expenses, Total | 3.5 | -2.8 | 1.1 | ||
Tulud majandustegevusest | -140.6 | -50 | -87.8 | -230.7 | 7.6 |
Intressitulud (kulu), muud tulud, neto | -0.6 | -5.9 | -5.1 | -7.8 | -8.8 |
Muud, neto | 0.6 | -0.6 | -1.2 | 15.2 | 1.2 |
Netotulu enne makse | -140.6 | -57.1 | -94.1 | -223.3 | 0 |
Netotulu pärast makse | -112 | -24.5 | -73.8 | -199.6 | 4.4 |
Vähemuse intress | 0 | 0 | 0.1 | 0.2 | |
Netotulu enne erikulusid | -112 | -24.5 | -73.8 | -199.5 | 4.6 |
Netotulu | -112 | -27.2 | -53.1 | -199.5 | 4.6 |
Arvestatav tulu, v a erikulud | -112 | -24.5 | -73.8 | -199.5 | 4.6 |
Arvestatav tulu, koos erikuludega | -112 | -27.2 | -53.1 | -199.5 | 4.6 |
Jaotamisele kuuluv netotulu | -112 | -27.2 | -53.1 | -199.5 | 4.6 |
Keskmine jaotamisele kuuluv aktsia kohta | 80.6 | 78 | 75 | 74.3 | 76 |
Jaotatav EPS, v a erakorralised kulud | -1.38958 | -0.3141 | -0.984 | -2.68506 | 0.06053 |
Jaotamisele kuuluv normaal-EPS | -1.25329 | -0.94827 | -0.984 | -1.8216 | 0.26664 |
Erakorralised kulud kokku | -2.7 | 20.7 | 0 | 0 | |
Ootamatud kulutused (tulu) | 16.9 | -76.7 | 0 | 98.7 | 24.1 |
Dividends per Share - Common Stock Primary Issue | 0 | ||||
Gain (Loss) on Sale of Assets | -0.6 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Kogutulu | 181.2 | 177.8 | 156.4 | 179.3 | 164.9 |
Tulu | 181.2 | 177.8 | 156.4 | 179.3 | 164.9 |
Kulud, Kokku | 59.2 | 53.9 | 50.4 | 49.7 | 48 |
Brutokasum | 122 | 123.9 | 106 | 129.6 | 116.9 |
Kogu tegevuskulu | 233.4 | 230 | 201.4 | 197.1 | 190.5 |
Müük/Üldine/admin kulud, kokku | 151.7 | 146.5 | 130.5 | 127.1 | 110.6 |
Uuringud ja arendus | 22.5 | 23.4 | 20.5 | 20.3 | 21.2 |
Ootamatud kulutused (tulu) | 0 | 6.2 | 0 | 0 | 10.7 |
Other Operating Expenses, Total | |||||
Tulud majandustegevusest | -52.2 | -52.2 | -45 | -17.8 | -25.6 |
Intressitulud (kulu), muud tulud, neto | 0.2 | 0.1 | 0.3 | -0.2 | -0.8 |
Netotulu enne makse | -52.6 | -52.1 | -44.2 | -17.9 | -26.4 |
Netotulu pärast makse | -54.7 | -42.3 | -35.1 | -14.1 | -20.5 |
Vähemuse intress | 0 | 0 | 0 | ||
Netotulu enne erikulusid | -54.7 | -42.3 | -35.1 | -14.1 | -20.5 |
Netotulu | -54.7 | -42.3 | -35.1 | -14.1 | -20.5 |
Arvestatav tulu, v a erikulud | -54.7 | -42.3 | -35.1 | -14.1 | -20.5 |
Arvestatav tulu, koos erikuludega | -54.7 | -42.3 | -35.1 | -14.1 | -20.5 |
Jaotamisele kuuluv netotulu | -54.7 | -42.3 | -35.1 | -14.1 | -20.5 |
Keskmine jaotamisele kuuluv aktsia kohta | 81.3 | 81.2 | 80.7 | 80.4 | 80.1 |
Jaotatav EPS, v a erakorralised kulud | -0.67282 | -0.52094 | -0.43494 | -0.17537 | -0.25593 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Jaotamisele kuuluv normaal-EPS | -0.67282 | -0.47131 | -0.43494 | -0.17537 | -0.1691 |
Gain (Loss) on Sale of Assets | |||||
Muud, neto | -0.6 | 0 | 0.5 | 0.1 | 0 |
Erakorralised kulud kokku |
- Aastas
- Kvartalis
2022 | 2021 | 2020 | 2020 | 2019 | |
---|---|---|---|---|---|
Käibevarad kokku | 274.6 | 484.8 | 389.4 | 331.7 | 348.6 |
Raha ja lühiajalised investeeringud | 114.9 | 339.8 | 150.7 | 217.8 | 136.9 |
Raha ja ekvivalendid | 3.3 | 258.4 | 117 | 163.7 | 93.2 |
Lühiajalised investeeringud | 58 | 81.4 | 33.7 | 54.1 | 43.7 |
Laekumata arved, neto | 101.6 | 91.3 | 91.5 | 71 | 138.6 |
Accounts Receivable - Trade, Net | 101.6 | 91.3 | 89.5 | 68.1 | 133.9 |
Total Inventory | 20.1 | 15.3 | 27.1 | 29.1 | 31.4 |
Prepaid Expenses | 38 | 38.4 | 120.1 | 13.8 | 41.7 |
Total Assets | 1198.7 | 1320.7 | 1418.8 | 1404.6 | 1562.7 |
Property/Plant/Equipment, Total - Net | 187.3 | 125.3 | 100.4 | 103 | 57.3 |
Property/Plant/Equipment, Total - Gross | 296.5 | 232.2 | 213.3 | 209.9 | 169.2 |
Accumulated Depreciation, Total | -109.2 | -106.9 | -112.9 | -106.9 | -111.9 |
Goodwill, Net | 286.8 | 239.2 | 329.2 | 327.6 | 417.2 |
Intangibles, Net | 379.7 | 404.1 | 576.5 | 605.3 | 684.7 |
Long Term Investments | 54.8 | 59 | 21 | 37 | 54.9 |
Total Current Liabilities | 137.2 | 204.3 | 145.9 | 147 | 117.8 |
Accounts Payable | 28.8 | 29.6 | 20.5 | 21.7 | 33.3 |
Accrued Expenses | 79.4 | 146.2 | 70 | 60.9 | 48.8 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 29 | 28.5 | 55.4 | 64.4 | 35.7 |
Total Liabilities | 312.9 | 352.9 | 537.8 | 486.4 | 473.8 |
Total Long Term Debt | 0 | 0 | 224.8 | 224.4 | 233.5 |
Long Term Debt | 0 | 224.8 | 224.4 | 233.5 | |
Deferred Income Tax | 3.5 | 35.8 | 71.3 | 26.6 | 82.6 |
Minority Interest | 0 | 0 | 0 | ||
Other Liabilities, Total | 172.2 | 112.8 | 95.8 | 88.4 | 39.9 |
Total Equity | 885.8 | 967.8 | 881 | 918.2 | 1088.9 |
Common Stock | 0.8 | 0.8 | 0.8 | 0.7 | 0.7 |
Additional Paid-In Capital | 1260.1 | 1226.3 | 1109.5 | 1096.6 | 1068 |
Retained Earnings (Accumulated Deficit) | -366.2 | -254.2 | -227 | -173.9 | 25.6 |
Other Equity, Total | -8.9 | -5.1 | -2.3 | -5.2 | -5.4 |
Total Liabilities & Shareholders’ Equity | 1198.7 | 1320.7 | 1418.8 | 1404.6 | 1562.7 |
Total Common Shares Outstanding | 81.2 | 80 | 75.4 | 74.7 | 73.5 |
Other Long Term Assets, Total | 15.5 | 8.3 | 2.3 | ||
Cash | 53.6 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Käibevarad kokku | 261.6 | 274.6 | 352.3 | 367.1 | 427.4 |
Raha ja lühiajalised investeeringud | 78.7 | 114.9 | 193.2 | 205.1 | 268.4 |
Raha ja ekvivalendid | 1.7 | 3.3 | 52.9 | 24.1 | 27.2 |
Lühiajalised investeeringud | 25.1 | 58 | 82.5 | 99.9 | 103.2 |
Laekumata arved, neto | 119.1 | 101.6 | 102.2 | 109.8 | 101.7 |
Accounts Receivable - Trade, Net | 119.1 | 101.6 | 102.2 | 109.8 | 101.7 |
Total Inventory | 21.8 | 20.1 | 19.6 | 15.4 | 15.6 |
Prepaid Expenses | 42 | 38 | 37.3 | 36.8 | 41.7 |
Total Assets | 1169.3 | 1198.7 | 1212 | 1210.2 | 1255.4 |
Property/Plant/Equipment, Total - Net | 203.3 | 187.3 | 178.1 | 135.7 | 116.6 |
Property/Plant/Equipment, Total - Gross | 315.5 | 296.5 | 286.6 | 241.3 | 220 |
Accumulated Depreciation, Total | -112.2 | -109.2 | -108.5 | -105.6 | -103.4 |
Goodwill, Net | 287.1 | 286.8 | 236.5 | 237.8 | 238.8 |
Intangibles, Net | 369.4 | 379.7 | 370.8 | 382.3 | 393.6 |
Long Term Investments | 30.4 | 54.8 | 66 | 78.5 | 70.8 |
Other Long Term Assets, Total | 17.5 | 15.5 | 8.3 | 8.8 | 8.2 |
Total Current Liabilities | 143.3 | 137.2 | 129.1 | 119.7 | 166 |
Accounts Payable | 36.5 | 28.8 | 29.6 | 21.7 | 27.1 |
Accrued Expenses | 80.7 | 79.4 | 75 | 73 | 72.7 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 26.1 | 29 | 24.5 | 25 | 66.2 |
Total Liabilities | 334.1 | 312.9 | 295.4 | 262.8 | 305.3 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Long Term Debt | |||||
Deferred Income Tax | 4.1 | 3.5 | 10.5 | 23.3 | 29.9 |
Minority Interest | 0 | 0 | 0 | 0 | |
Other Liabilities, Total | 186.7 | 172.2 | 155.8 | 119.8 | 109.4 |
Total Equity | 835.2 | 885.8 | 916.6 | 947.4 | 950.1 |
Common Stock | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 |
Additional Paid-In Capital | 1262.7 | 1260.1 | 1251 | 1244.3 | 1231.6 |
Retained Earnings (Accumulated Deficit) | -420.9 | -366.2 | -323.9 | -288.8 | -274.7 |
Other Equity, Total | -7.4 | -8.9 | -11.3 | -8.9 | -7.6 |
Total Liabilities & Shareholders’ Equity | 1169.3 | 1198.7 | 1212 | 1210.2 | 1255.4 |
Total Common Shares Outstanding | 81.5 | 81.2 | 80.9 | 80.6 | 80.3 |
Other Current Assets, Total | |||||
Current Port. of LT Debt/Capital Leases | |||||
Cash | 51.9 | 53.6 | 57.8 | 81.1 | 138 |
- Aastas
- Kvartalis
2022 | 2021 | 2020 | 2020 | 2019 | |
---|---|---|---|---|---|
Netotulu/algväärtus | -112 | -27.2 | -199.5 | 4.6 | |
Raha majandustegevusest | -106.3 | 18.2 | 60.7 | 83.7 | |
Raha majandustegevusest | 52.7 | 62.8 | 72 | 73 | |
Deferred Taxes | -30.8 | -32.1 | -55.8 | 18.6 | |
Mittelikviidsed varad | 85.3 | -105.7 | 128.9 | 24.6 | |
Cash Taxes Paid | 1.8 | -85.4 | 1 | 6.5 | |
Muutused tööjõus | -101.5 | 120.4 | 115.1 | -37.1 | |
Tulu investeeringutelt | -77.5 | 274.4 | 19.3 | -286.4 | |
Kapitalikulutused | -45.3 | -18 | -10.2 | -8.6 | |
Muud rahavood investeeringutelt, kokku | -32.2 | 292.4 | 29.5 | -277.8 | |
Rahavood investeeringutelt | -8 | -150.6 | -10 | 182.3 | |
Rahavoogudesse investeerimine | -3.7 | -4.5 | -4.9 | -1.4 | |
Aktsiate emiteerimine (tagasiost), neto | -4.3 | 80.3 | 3.5 | -41.3 | |
Laenu väljastamine (kustutamine), neto | 0 | -226.4 | -8.6 | 225 | |
Muutused valuutakursside kõikumisest | -0.6 | -0.6 | 0.5 | 2.7 | |
Rahaline kogumuutus | -192.4 | 141.4 | 70.5 | -17.7 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -54.7 | -112 | -69.7 | -34.6 | -20.5 |
Cash From Operating Activities | -33.2 | -106.3 | -98.6 | -96.8 | -46.5 |
Cash From Operating Activities | 19.4 | 52.7 | 39 | 25.9 | 13 |
Deferred Taxes | 0.1 | -30.8 | -22 | -10.6 | -5.9 |
Non-Cash Items | 26.3 | 85.3 | 60.3 | 37.1 | 24.3 |
Cash Taxes Paid | 0.3 | 1.8 | -1.6 | 1 | 0.3 |
Changes in Working Capital | -24.3 | -101.5 | -106.2 | -114.6 | -57.4 |
Cash From Investing Activities | 34.6 | -77.5 | -41.9 | -53.3 | -41.3 |
Capital Expenditures | -23.5 | -45.3 | -30.7 | -13 | -6.3 |
Other Investing Cash Flow Items, Total | 58.1 | -32.2 | -11.2 | -40.3 | -35 |
Cash From Financing Activities | -4.9 | -8 | -5.9 | -2.3 | -4.8 |
Financing Cash Flow Items | -3.7 | -0.7 | 0 | 0 | |
Issuance (Retirement) of Stock, Net | -4.9 | -4.3 | -5.2 | -2.3 | -4.8 |
Issuance (Retirement) of Debt, Net | 0 | 0 | 0 | 0 | |
Foreign Exchange Effects | 0.2 | -0.6 | -1.3 | -0.8 | -0.6 |
Net Change in Cash | -3.3 | -192.4 | -147.7 | -153.2 | -93.2 |
Investori nimi | Investori liik | Ringluse protsent | Hoitud osakud | Muutus osakutes | Hoidmise kuupäev | Hinnang käibele |
---|---|---|---|---|---|---|
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 15.788 | 12875892 | -297506 | 2023-03-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 11.3836 | 9283920 | -13347 | 2023-03-31 | LOW |
Camber Capital Management LP | Hedge Fund | 8.5831 | 7000000 | 0 | 2023-03-31 | MED |
Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 8.2531 | 6730839 | -56384 | 2023-03-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 5.6439 | 4602919 | -417504 | 2023-03-31 | LOW |
Glenview Capital Management, LLC | Hedge Fund | 5.1439 | 4195112 | 1097344 | 2023-03-31 | MED |
EARNEST Partners, LLC | Investment Advisor/Hedge Fund | 3.7531 | 3060838 | -243618 | 2023-03-31 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 3.3406 | 2724396 | 90532 | 2023-03-31 | LOW |
Managed Account Advisors LLC | Investment Advisor | 3.3366 | 2721202 | 212533 | 2023-03-31 | LOW |
Artisan Partners Limited Partnership | Investment Advisor | 2.706 | 2206858 | -11499 | 2023-03-31 | LOW |
Disciplined Growth Investors, Inc. | Investment Advisor | 2.5612 | 2088784 | -183660 | 2023-03-31 | LOW |
D. E. Shaw & Co., L.P. | Hedge Fund | 2.4307 | 1982325 | 125025 | 2023-03-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.9669 | 1604107 | 78333 | 2023-03-31 | LOW |
Balyasny Asset Management LP | Hedge Fund | 1.9483 | 1588977 | 1588977 | 2023-03-31 | HIGH |
Millennium Management LLC | Hedge Fund | 1.6987 | 1385391 | -87025 | 2023-03-31 | HIGH |
SEI Investments Management Corporation | Investment Advisor/Hedge Fund | 1.5919 | 1298296 | 85662 | 2023-03-31 | LOW |
Goldman Sachs Asset Management, L.P. | Investment Advisor | 1.3191 | 1075754 | 69569 | 2023-03-31 | LOW |
Pictet Asset Management Ltd. | Investment Advisor/Hedge Fund | 1.0709 | 873338 | 572778 | 2023-03-31 | LOW |
Charles Schwab Investment Management, Inc. | Investment Advisor | 1.0676 | 870718 | 30084 | 2023-03-31 | LOW |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.914 | 745403 | -7191 | 2023-03-31 | LOW |
Miks valida Capital.com? Meie numbrid räägivad iseenda eest.
Capital.com Group535K+
Kauplejad
87K+
Igakuiste aktiivsete klientide arv
$113M+
Igakuine investeerimise maht
$64M+
Igakuiselt välja võetud
Kauplemiskalkulaator
Arvutage oma hüpoteetiline võit/kaotus, kui oleksite avanud CFD-tehingu ühel kindlal kuupäeval (valige kuupäev) ja sulgenud teisel kuupäeval (valige kuupäev).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Myriad Genetics Company profile
Ettevõttest Myriad Genetics
Myriad Genetics, Inc. (Myriad) on geneetiliste testide ja täppismeditsiini ettevõte. Myriad tegeleb ümberkujundavate molekulaardiagnostiliste testide avastamise, arendamise ja turustamisega. Ta tegutseb kahes segmendis: diagnostika ja muud. Diagnostikasegment pakub teste ja koostööd testide arendamisel, mille eesmärk on määrata kindlaks haiguse tekkerisk, hinnata haiguse progresseerumise riski ja suunata raviotsuseid meditsiinilistel erialadel, kus kriitilised geneetilised teadmised võivad edendada patsiendi ravi. Muu segment pakub testimistooteid ja -teenuseid farmaatsia-, biotehnoloogia- ja meditsiiniuuringute tööstusele, teadus- ja arendustegevust ning kliinilisi teenuseid patsientidele ning hõlmab ka ettevõtte teenuseid, näiteks finants-, personali-, õigus- ja infotehnoloogiateenuseid. Ettevõtte toodete hulka kuuluvad myRisk, BRACAnalysis, BRACAnalysis CDx myChoice CDx, Prolaris, EndoPredict, Foresight ja Prequel.
Industry: | Laboratory Diagnostic & Testing Substances |
320 Wakara Way
SALT LAKE CITY
UTAH 84108
US
Tuluaruanne
- Annual
- Quarterly
Teised on vaadanud veel
Kas otsite jätkuvalt vahendajat, keda saab usaldada?
Ühinege 535,000+ kauplejaga üle kogu maailma, kes valisid kauplemiseks veebisaidi Capital.com